Deferasirox treatment for myelodysplastic syndromes: real-life efficacy and safety in a single-institution patient population
Annals of Hematology, 05/14/2012
Clinical Article
Breccia M et al. – The oral iron chelator deferasirox is effective and safe when used in myelodysplastic syndromes (MDS) patients with transfusion requirement, also if administered concomitantly with other drugs.



